Lnc-ATB contributes to gastric cancer growth through a MiR-141-3p/TGFβ2 feedback loop

被引:100
作者
Lei, Kecheng [1 ,2 ]
Liang, Xin [1 ,2 ]
Gao, Yuwei [1 ,2 ]
Xu, Baixue [1 ,2 ]
Xu, Yichun [1 ,2 ]
Li, Yueqi [1 ,2 ]
Tao, Yiwen [3 ]
Shi, Weibin [4 ]
Liu, Jianwen [1 ,2 ]
机构
[1] East China Univ Sci & Technol, State Key Lab Bioreactor Engn, Sch Pharm, Shanghai, Peoples R China
[2] East China Univ Sci & Technol, Shanghai Key Lab New Drug Design, Sch Pharm, Shanghai, Peoples R China
[3] Guangzhou Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China
[4] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gen Surg, Shanghai, Peoples R China
关键词
Gastric cancer; lnc-ATB; miR-141-3p; TGF-beta; LONG NONCODING RNA; INVASION-METASTASIS CASCADE; TGF-BETA; CELL-PROLIFERATION; POOR-PROGNOSIS; EXPRESSION; PROMOTES; PHOTOSENSITIZER; INFLAMMATION; INCREASES;
D O I
10.1016/j.bbrc.2017.01.094
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The long noncoding RNA (IncRNA) ATB is an important regulator in human tumors. Here, we aimed to investigate the potential molecular mechanisms of Inc-ATB in gastric cancer (GC) tumorigenesis. RT-qPCR analysis was used to detect Inc-ATB expression level in 20 pairs of gastric cancer tissues and adjacent normal gastric mucosa tissues (ANTs). Moreover, the biological role of lnc-ATB was determined in vitro. We found that lnc-ATB was significantly upregulated in GC tissues compared to Inc-ATB expression in ANTs. These high lnc-ATB expression levels predicted poor prognosis in GC patients. Low levels of Inc-ATB inhibited GC cell proliferation and cell cycle arrest in vitro. Lnc-ATB was found to directly bind miR-141-3p. Moreover, TGF-beta actives Inc-ATB and TGF-beta 2 directly binds mir-141-3p. Finally, we demonstrated that Inc-ATB fulfilled its oncogenic roles in a ceRNA-mediated manner. Our study suggests that lnc-ATB promotes tumor progression by interacting with miR-141-3p and that Lnc-ATB may be a valuable prognostic predictor for GC. In conclusion, the positive feedback loop of lnc-ATB/miR-141-3p/TGF-132 may be a potential therapeutic target for the treatment of GC. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:514 / 521
页数:8
相关论文
共 37 条
[1]  
[Anonymous], 2016, ONCOTARGET
[2]  
[Anonymous], ONCOTARGET
[3]  
[Anonymous], 2016, TUMOUR BIOL
[4]  
Chan BA, 2016, ONCOLOGY-NY, V30, P635
[5]   miR-141 suppresses proliferation and motility of gastric cancer cells by targeting HDGF [J].
Chen, Bitao ;
Huang, Tao ;
Jiang, Jun ;
Lv, Lei ;
Li, Hongxing ;
Xia, Shitao .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2014, 388 (1-2) :211-218
[6]   The long non-coding RNA HOTTIP enhances pancreatic cancer cell proliferation, survival and migration [J].
Cheng, Yating ;
Jutooru, Indira ;
Chadalapaka, Gayathri ;
Corton, J. Christopher ;
Safe, Stephen .
ONCOTARGET, 2015, 6 (13) :10840-10852
[7]   Long non-coding RNAs in stem cells and cancer [J].
Eades, Gabriel ;
Zhang, Yong-Shu ;
Li, Qing-Lin ;
Xia, Ji-Xiang ;
Yao, Yuan ;
Zhou, Qun .
WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (02) :134-141
[8]   The bright side of dark matter: lncRNAs in cancer [J].
Evans, Joseph R. ;
Feng, Felix Y. ;
Chinnaiyan, Arul M. .
JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (08) :2775-2782
[9]  
He PH, 2016, AM J TRANSL RES, V8, P1780
[10]  
Iguchi T, 2015, ANTICANCER RES, V35, P1385